Nanobiotix S.A. Cash And Cash Equivalents
Nanobiotix S.A. (NNBXF) had Cash And Cash Equivalents of EUR 52.75 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-31
- 2025-12-31: Cash And Cash Equivalents 52.75M EUR.
- 2025-06-30: Cash And Cash Equivalents 28.82M EUR.
- 2024-12-31: Cash And Cash Equivalents 49.74M EUR.
- 2024-06-30: Cash And Cash Equivalents 66.33M EUR.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | 52.75M EUR 20-F · filed 2026-03-31 |
| 2025-06-30 | 28.82M EUR 6-K · filed 2025-09-30 |
| 2024-12-31 | 49.74M EUR 20-F · filed 2026-03-31 |
| 2024-06-30 | 66.33M EUR 6-K · filed 2025-09-30 |
| 2023-12-31 | 75.28M EUR 20-F · filed 2026-03-31 |
| 2023-06-30 | 21.63M EUR 6-K · filed 2024-09-18 |
| 2022-12-31 | 41.39M EUR 20-F · filed 2026-03-31 |
| 2022-06-30 | 63.02M EUR 6-K · filed 2023-09-26 |
| 2021-12-31 | 83.92M EUR 20-F · filed 2025-04-02 |
| 2021-06-30 | 102.34M EUR 6-K · filed 2022-09-28 |
| 2020-12-31 | 119.15M EUR 20-F · filed 2024-04-24 |
| 2020-06-30 | 26.59M EUR 6-K · filed 2021-09-08 |
| 2019-12-31 | 35.09M EUR 20-F · filed 2023-04-24 |
| 2018-12-31 | 36.20M EUR 20-F · filed 2022-04-08 |
| 2017-12-31 | 47.21M EUR 20-F/A · filed 2021-04-08 |